| Structure | Chemical Name | CAS | MF |
|
Methanamine, 1,1,1-trifluoro-N-(fluoromethyl)-N-methyl- (9CI)
|
191605-89-7
|
C3H5F4N
|
|
Methanone, cyclopentyl(2S)-2-pyrrolidinyl- (9CI)
|
607403-68-9
|
C10H17NO
|
|
3-Methacryloxypropylmethylsiloxane - dimethylsiloxane copolymer
|
|
|
|
Methanimidamide, N-hydroxy-N-[6-(1-methylethoxy)-3-pyridinyl]- (9CI)
|
380826-66-4
|
C9H13N3O2
|
|
2'-(4-Methacryloxyphenyl)-5-(4-methyl-1-piper-azinyl)-2,5'-bibenzimidazolyl trihydrochloride
|
|
C29H30Cl2N6O2
|
|
Methacryloxymethyltriethoxysilane
|
5577-72-0
|
C11H22O5Si
|
|
4-(4-Methanesulfonyl-phenyl)-6-methyl-2-quinolin-3-ylmethyl-5-(4-trifluoromethyl-phenyl)-2H-pyridazin-3-one
|
|
C29H22F3N3O3S
|
|
Methanone, (5-ethyl-2-hydroxyphenyl)-4-pyridinyl- (9CI)
|
734498-48-7
|
C14H13NO2
|
|
4,7-Methano-1H-inden-5-ol, 3a,4,5,6,7,7a-hexahydro-, (3aS,4S,5R,7S,7aS)- (9CI)
|
501929-86-8
|
C10H14O
|
|
1-Methanesulfonyl-11-hydroxy-3,6,9-trioxaundecane
|
65883-12-7
|
C9H20O7S
|
|
Methanone, (5-ethyl-1H-pyrrol-2-yl)(3-methoxyphenyl)- (9CI)
|
728010-85-3
|
C14H15NO2
|
|
(+/-)-Methadone hydrochloride
|
|
C21H28ClNO
|
|
|
(+/-) METHADONE (D3, 98%) 1.0 MG/ML IN METHANOL
|
|
|
|
1-Methanesulfonyl-piperidine-4-carboxylic acid
|
280772-00-1
|
C7H13NO4S
|
|
Methanamine, N-[(2,2-dichlorocyclopropyl)methylene]- (9CI)
|
149511-04-6
|
C5H7Cl2N
|
|
1,4-Methanonaphthalene-5,6-dione, 1,4,4a,8a-tetrahydro-7,8-dimethyl-, endo- (8CI)
|
32349-69-2
|
C13H14O2
|
|
(+/-) Methamphetamine (d8, 98%) 100 ug/mL in methanol
|
|
C10H7D8N
|
|
(+/-) Methamphetamine (d5, 98%) 10 ug/mL in methanol
|
|
C10H10D5N
|
|
Methanone, phenyl(1,4,5,6-tetrahydro-4-methyl-2-pyrimidinyl)- (9CI)
|
806638-35-7
|
C12H14N2O
|
|
METHAZOLE
|
20354-26-1
|
C9H6Cl2N2O3
|
|
Methallyl phenyl ether
|
5820-22-4
|
C10H12O
|
|
METHAMPICILLIN
|
6489-97-0
|
C17H19N3O4S
|
|
1-(4-Methanesulfonyl-benzyl)-3-methyl-6-(4-pyridin-2-yl-piperazin-1-yl)-1H-pyrimidine-2,4-dione
|
|
C22H25N5O4S
|
|
3-(Triethoxysilyl)propyl methacrylate
|
21142-29-0
|
C13H26O5Si
|
|
METHALLYL SULFIDE
|
53926-81-1
|
C8H14S
|
|
Methacryloxypropylbis(trimethylsiloxy)methylsilane
|
19309-90-1
|
C14H32O4Si3
|
|
|
Methacryloxypropyl terminated polydimethylsiloxane, viscosity 70-100 cSt.
|
|
|
|
(+/-)-Methamphetamine
|
4846-07-5
|
C10H15N
|
|
(1-methacryloyl-4-piperidinyl)(diphenyl)methanol
|
|
C22H25NO2
|
|
Methanesulfonamide, N-(2-hydroxy-5-methylphenyl)- (9CI)
|
791840-51-2
|
C8H11NO3S
|
|
Methanaminium, N-[(5-amino-4-isoxazolyl)methylene]-N-methyl- (9CI)
|
774477-05-3
|
C6H10N3O+
|
|
Methanone, (1-ethyl-1H-tetrazol-5-yl)phenyl-, oxime (9CI)
|
500206-57-5
|
C10H11N5O
|
|
Methanol, 1,3-dithian-2-ylidene- (9CI)
|
775227-79-7
|
C5H8OS2
|
|
11-(Methacryloylamino)undecanoic acid
|
59178-93-7
|
C15H27NO3
|
|
Methanehydrazonic acid, N-2-benzothiazolyl-, ethyl ester (9CI)
|
89969-39-1
|
C10H11N3OS
|
|
Methanone, (2-amino-5-ethyl-1-cyclopenten-1-yl)phenyl- (9CI)
|
690660-91-4
|
C14H17NO
|
|
Methanimidamide, N-hydroxy-N-(1-methyl-1H-benzimidazol-2-yl)- (9CI)
|
382136-62-1
|
C9H10N4O
|
|
Methamphetamine HCl controlled substance cii USP(CRM standard)
|
|
C10H16ClN
|
|
Methacryloylaminopropyltrimethylammonium methyl sulfate
|
51441-65-7
|
C11H24N2O5S
|
|
Methanamine, N-(2-pyridinylmethylene)-, N-oxide (9CI)
|
20251-40-5
|
C7H8N2O
|
|
Methanone, [(6R)-6-ethyl-1-cyclohexen-1-yl]phenyl- (9CI)
|
521086-91-9
|
C15H18O
|
|
Methanesulfonic acid (4S,5S)-5-[(S)-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-methanesulfonyloxy-methyl]-2,2-dimethyl-[1,3]dioxolan-4-ylmethyl ester
|
7115-24-4
|
C14H26O10S2
|
|
METHANTHELINE BROMIDE
|
53-46-3
|
CH3-
|
|
|
Methacrylate Cuvettes with 4 Clear Sides, 4.5ml capacity
|
|
|
|
Methanone, (2,4-dichlorophenyl)[(2R,3S)-3-phenyloxiranyl]-
|
691178-33-3
|
C15H10Cl2O2
|
|
1,4-Methanonaphthalene-5,6-dione, 1,4,4a,8a-tetrahydro-7,8-dimethyl- (8CI)
|
17412-44-1
|
C13H14O2
|
|
Methanaminium, N,N,N-trimethyl-, salt with [[3-(2,2-dicyanoethenyl)-2-phenyl-2-cyclohexen-1-ylidene]methyl]propanedinitrile (1:1)
|
98826-75-6
|
C24H25N5
|
|
3-Methacryloxypropylmethyldimethoxysilane
|
14513-34-9
|
C10H20O4Si
|
|
Methanaminium, N,N,N-trimethyl-, salt with [[3-(2,2-dicyanoethenyl)-2-methyl-2-cyclohexen-1-ylidene]methyl]propanedinitrile (1:1)
|
98826-81-4
|
C19H23N5
|
|
Methanamine, N-1-azabicyclo[4.1.0]hept-7-ylidene-, (E)- (9CI)
|
203644-77-3
|
C7H12N2
|
|
Methanone, 3-isoxazolyl-4-isoxazolyl- (9CI)
|
60295-63-8
|
C7H4N2O3
|
|
Methanone, (1-chlorocyclopropyl)(4-fluorophenyl)- (9CI)
|
117107-73-0
|
C10H8ClFO
|
|
2-Methanesulfonyl-quinoline
|
17075-19-3
|
C10H9NO2S
|
|
(+-)-Methadone hydrochloride--DEA
|
125-56-4
|
C21H28ClNO
|
|
2,6-Methano-3-benzazocine-6,8(1H)-diol, 2,3,4,5-tetrahydro-3-methyl- (9CI)
|
763863-85-0
|
C13H17NO2
|
|
Methanephosphonic acid = methyl phosphonic acid
|
|
C2H10O6P2
|
|
4-(4-Methanesulfonyl-piperazin-1-ylmethyl)-phenylamine
|
|
C12H19N3O2S
|
|
Methanone, (5-ethyl-1H-pyrrol-2-yl)-4-pyridinyl- (9CI)
|
728010-87-5
|
C12H12N2O
|
|
Methabenzthiazuron
|
18691-97-9
|
C10H11N3OS
|
|
Methanesulphonyl-2-chloroethylamide
|
|
C3H8ClNO2S
|
|
4-(4-Methanesulfonyl-phenyl)-[1,4]diazepane-1-carboxylic acid (2-trifluoromethyl-phenyl)-amide
|
|
C20H22F3N3O3S
|
|
Methacryloxyethyl thiocarbamoyl rhodamine B
|
|
C35H40ClN3O5S
|
|
1,5-Methanopentalen-4(1H)-one, hexahydro-3,6a-dihydroxy-1,7,7-trimethyl-, (1S,3R,3aS,5S,6aR)- (9CI)
|
434342-98-0
|
C12H18O3
|
|
Methadone hydrochloride
|
1095-90-5
|
CH3ClO
|
|
3-(Methacryloyloxy)propyltris(trimethylsiloxy)silane
|
17096-07-0
|
C16H38O5Si4
|
|
(Methanesulfonyl-phenethyl-amino)-acetic acid
|
|
C11H15NO4S
|
|
1-Methanesulfonyl-piperidine-4-carboxylic acid hydrazide
|
312515-49-4
|
C7H15N3O3S
|
|
1-(6-Methanesulfonyl-2-phenyl-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yl)-piperidine-4-carboxylic acid ethyl ester
|
|
C22H28N4O4S
|
|
Methanol-d3
|
1849-29-2
|
CHD3O
|
|
4-Methanesulfonyl-benzoic acid methyl ester
|
22821-70-1
|
C9H10O4S
|
|
Methanamine, N-[(4-fluoro-2-methylphenyl)methylene]-1-(trimethylsilyl)- (9CI)
|
815630-75-2
|
C12H18FNSi
|
|
Methanesulfonamide, N-[(3S)-2-oxo-3-oxetanyl]- (9CI)
|
406951-05-1
|
C4H7NO4S
|
|
5-Methanesulphonamido-2-hydroxyacetophenone
|
94094-49-2
|
C9H11NO4S
|
|
|
Methacrylic acid-methylmethacrylate copolymer (1:1)reference spectrum epm(CRM standard)
|
|
|
|
METHACRYLOYL FLUORIDE
|
381-67-9
|
C4H5FO
|
|
3-Methacryloxypropyltris(vinyldimethylsiloxy)silane
|
17096-10-5
|
C19H38O5Si4
|
|
Methanimidamide, N-(3-hydroxy-2-pyridinyl)- (9CI)
|
193413-17-1
|
C6H7N3O
|
|
Methanesulfonamide
|
3144-09-0
|
CH5NO2S
|
|
Methanimidamide, N-2-benzothiazolyl-N,N-dimethyl- (9CI)
|
30006-84-9
|
C10H11N3S
|
|
(+/-)-Methamphetamine-d14
|
362044-12-0
|
C10H15N
|
|
Methanone, (2-amino-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)(4-ethoxyphenyl)-
|
|
C15H17N3O2
|
|
[4-(4-Methanesulfonyl-phenyl)-[1,4]diazepan-1-yl]-o-tolyl-methanone
|
|
C20H24N2O3S
|
|
4-[4-(Methacryloyloxy)butoxy]benzenecarboxylic acid
|
92174-21-5
|
C15H18O5
|
|
Methanimidamide, N,N-dimethyl-N-5-pyrimidinyl-, (E)- (9CI)
|
193014-40-3
|
C7H10N4
|
|
(Methacryloxymethyl)bis(trimethylsiloxy)methylsilane
|
18166-40-0
|
C12H28O4Si3
|
|
Methanol, [(6-chloro-2-benzothiazolyl)amino]- (9CI)
|
71085-91-1
|
C8H7ClN2OS
|
|
Methanol, [(3-aminopropyl)imino]bis- (9CI)
|
289045-31-4
|
C5H14N2O2
|
|
4-Methacryloxy-2-hydroxybenzophenone
|
2035-72-5
|
C17H14O4
|
|
Methanesulfinic acid, (methylamino)(2-pyridinylimino)- (9CI)
|
98548-10-8
|
C7H9N3O2S
|
|
METHACHOLINE CHLORIDE
|
62-51-1
|
C8H18ClNO2
|
|
1-Methanesulfonyl-piperazine
|
55276-43-2
|
C5H12N2O2S
|
|
Methanesulfonic acid 2-isopropoxyethyl ester
|
235097-76-4
|
C6H14O4S
|
|
Methanone, (2-hydroxyphenyl)(1-methyl-1H-pyrazol-4-yl)- (9CI)
|
771481-15-3
|
C11H10N2O2
|
|
Methacryloxypropyl terminated polydimethylsiloxane
|
146632-07-7
|
C12H26O4Si2
|
|
|
MethacrylicAcid(Maa)
|
|
|
|
Methanol, (2-pyridinyloxy)-, acetate (ester) (9CI)
|
750649-33-3
|
C8H9NO3
|
|
Methanamine, 1-cyclopentylidene-N,N-dimethyl- (9CI)
|
183137-37-3
|
C8H15N
|
|
|
Methacetin (methoxy-13C, 99%)
|
|
|
|
3-(Methacryloylamino)benzeneboronic acid
|
|
C10H12BNO3
|
|
|
METHADONE HCL CONTROLLED SUBSTANCE CII USP(CRM STANDARD)
|
|
|